Neurologic disease associated with 17D-204 yellow fever vaccination: A report of 15 cases

Vaccine

Volumn 25, Issue 10, 2007, Pages 1727-1734

  McMahon, Ann W ^a   Eidex, Rachel B ^a   Marfin, Anthony A ^a   Russell, Michelle ^a   Sejvar, James J ^a   Markoff, Lewis ^a   Hayes, Edward B ^a   Chen, Robert T ^a   Ball, Robert ^a   Braun, M Miles ^a   Cetron, Martin ^a  

^a NONE   (United States)

Author keywords

Adverse event; Neurologic; Yellow fever vaccine

Indexed keywords

IMMUNOGLOBULIN; METHYLPREDNISOLONE SODIUM SUCCINATE; YELLOW FEVER VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG MEGADOSE; ENCEPHALITIS; ENCEPHALOMYELITIS; FEMALE; FEVER; GUILLAIN BARRE SYNDROME; HUMAN; MALE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PLEOCYTOSIS; PRIORITY JOURNAL; YELLOW FEVER;

ADOLESCENT; ADULT; AGED; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; MALE; MIDDLE AGED; UNITED STATES; VACCINATION; YELLOW FEVER VACCINE;

EID: 33846674490     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.11.027     Document Type: Article

References (30)

1. Sanders E.J., Marfin A.A., Tukei P.M., Kuria G., Ademba G., Agata N.N., et al. First recorded outbreak of yellow fever in Kenya, 1992-1993. I. Epidemiologic investigations. Am J Trop Med Hyg 59 4 (1998) 644-649
2. Vasconcelos P.F., Rodrigues S.G., Degallier N., Moraes M.A., da Rosa J.F., da Rosa E.S., et al. An epidemic of sylvatic yellow fever in the southeast region of Maranhao State, Brazil, 1993-1994: epidemiologic and entomologic findings. Am J Trop Med Hyg 57 2 (1997) 132-137
3. De Cock K.M., Monath T.P., Nasidi A., Tukei P.M., Enriquez J., Lichfield P., et al. Epidemic yellow fever in eastern Nigeria, 1986. Lancet 1 8586 (1988) 630-633
4. Marfin A.A., Eidex R.B., and Monath T.P. In: Guerrant R.L., Walker D.H., and Weller P.F. (Eds). Tropical infectious diseases: principles, pathogens, & practice (2006), Elsevier, Philadelphia, PA 797-812
5. Stones P.H., and MacNamara F.N. Encephalitis following neurotropic yellow fever vaccine administered by scarification in Nigeria: epidemiological and laboratory studies. Trans R Soc Trop Med Hyg 49 2 (1955) 176-186
6. Monath T.P. Yellow fever vaccine. In: Plotkin S.A., and Orenstein W.A. (Eds). Vaccine. 4th ed. (2004), Elsevier, Philadelphia, PA 1095-1176
7. Recommendations of the Immunization Practices Advisory Committee. Yellow fever vaccine. MMWR Morb Mortal Wkly Rep 18 (1969) 189
8. Anon. Fatal viral encephalitis following 17D yellow fever vaccine inoculation. Report of a case in a 3-year-old child. JAMA 198 (1966) 203-204
9. Kengsakul K., Sathirapongsasuti K., and Punyagupta S. Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection. J Med Assoc Thai 85 1 (2002) 131-134
10. Marfin A.A., Eidex R.S., Kozarsky P.E., and Cetron M.S. Yellow fever and Japanese encephalitis vaccines: indications and complications. Infect Dis Clin North Am 19 1 (2005) 151-168
11. Khromava A.Y., Eidex R.B., Weld L.H., Kohl K.S., Bradshaw R.D., Chen R.T., et al. Yellow fever vaccine: An updated assessment of advanced age as a risk factor for serious adverse events. Vaccine 23 (2005) 3256-3263
12. ®. Vaccine 22 (2004) 2103-2105
13. Anon. Notice to readers: fever, jaundice, and multiple organ system failure associated with 17D-derived yellow fever vaccination, 1996-2001. MMWR 50 (2001) 643-645
14. Martin D.A., Muth D.A., Brown T., Johnson A.J., Karabatsos N., and Roehrig J.T. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol 38 5 (2000) 1823-1826
15. Hughes R.A.C., and Rees J.H. Clinical and epidemiologic features of Guillain-Barre Syndrome. JID 176 (1997) S92-S98
16. Davison K.L., Crowcroft N.S., Ramsay M.E., Brown D.W.G., and Andrews N.J. Viral encephalitis in England, 1989-1998: What did we miss?. EID 9 (2003) 234-240
17. Nicolosi A., Hauser A., Beghi E., and Kurland L.T. Epidemiology of central nervous system infections in Olmsted County, Minnesota, 1950-1081. JID 154 (1986) 399-408
18. Beghi E., Nicolosi A., Kurland L.T., Mulder D.W., Hauser W.A., and Shuster L. Encephalitis and aseptic meningitis, Olmsted County, Minnesota, 1950-1081: I. Epidemiology. Ann Neurol 16 (1984) 283-294
19. Anon. Adverse events associated with 17D-derived yellow fever vaccination-United States, 2001-2002. MMWR 51 44 (2002) 989-993
20. Varricchio F., Iskander J., Destefano F., Ball R., Pless R., Braun M.M., et al. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J 23 4 (2004) 287-294
21. Sejvar J.J., Chowdary Y., Schomogyi M., Setevens J., Patel J., Karem K., et al. Human monkeypox infection: a family cluster in the Midwestern United States. JID 190 (2004) 1833-1840
22. Burke D., Nisalak A., Ussery M., Laorakpongse T., and Chantavibul S. Kinetics of IgM and IgG responses to Japenese encephalitis virus in human serum and cerebrospinal fluid. J Infect Dis 151 (1985) 1093-1099
23. Rosenthal S., and Chen R.T. Reporting sensitivities of two passive surveillance systems for vaccine adverse events. Am J Public Health 85 (1995) 1706-1709
24. Chen R.T., DeStefano F., Davis R.L., Jackson L.A., Thompson R.S., Mullooly J.P., et al. Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA. Bull WHO 78 (2000) 186-194
25. Wasserman G.M., Grabenstein J.D., Pittman P.R., Rubertone M.V., Gibbs P.P., Wang L.Z., et al. Analysis of adverse events after anthrax immunization in US Army medical personnel. J Occup Environ Med 45 3 (2003) 222-233
26. Bellini W.J., Rota J.S., Lowe L.E., Katz R.S., Dyken P.R., Zaki S.R., et al. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized. J Infect Dis 192 10 (2005) 1686-1693
27. Langmuir A.D., Bregman D.J., Kurland L.T., Nathanson N., and Victor M. An epidemiologic and clinical evaluation of Guillain-Barre Syndrome reported in association with the administration of swine influenza vaccines. Am J Epidemiol 119 (1984) 841-879
28. Henderson D.A., Borio L.L., and Lane J.M. Smallpox and vaccinia. In: Plotkin S.A., and Orenstein W.A. (Eds). Vaccine. 4th ed. (2004), Elsevier, Philadelphia, PA 123-154
29. Sejvar J.J., LaButta R.J., Chapman L.E., Grabenstein J.D., Iskander J., and Lane J.M. Neurologic adverse events associated with smallpox vaccination in the United States, 2002-2004. JAMA 294 (2005) 2744-2750
30. In: Baciu A., Anason A.P., Stratton K., and Strom B. (Eds). The smallpox vaccination program: public health in an age of terrorism (2005), The National Academies Press, Washington, DC